IGC · IGC Pharma, Inc. · Executive Compensation
Market Cap
$29.20M
Shares
103.38M
Volume · Oct 6
743.2K
Avg daily vol (3M)
696.05K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $568 |
| Claudia Grimaldi | Vice President, CCO, and PFO | $259 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $1,821 |
| Claudia Grimaldi | Vice President, CCO, and PFO | $717 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $1,006 |
| Claudia Grimaldi | Vice President, CCO, and PFO | $320 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $5,547 |
| Claudia Grimaldi | Vice President, CCO, and PFO | $761 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $801 |
| Claudia Grimaldi | Vice President, CCO, and PFO | $248 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $719,000 |
| Claudia Grimaldi | Vice President, PFO | $321,000 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ram Mukunda | President and CEO | $712,000 |
| Claudia Grimaldi | Vice President, PFO | $297,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Terry Lierman | independent Class B director | Appointed | 2024-03-13 |
| Jim Moran | member of both the Company's Audit and Compensation Committees | Appointed | 2022-12-29 |
| John E. Lynch | Director | Terminated | 2022-12-29 |
| Claudia Grimaldi | Class A director | Appointed | 2022-09-09 |
| James Moran | Class C director | Appointed | 2022-09-09 |
| Ram Mukunda | Class C director | Appointed | 2022-09-09 |